Publications in collaboration with researchers from Assistance Publique -Hopitaux De Paris (1)

2016

  1. The F4/AS01B HIV-1 Vaccine Candidate Is Safe and Immunogenic, but Does Not Show Viral Efficacy in Antiretroviral Therapy-Naive, HIV-1-Infected Adults: A Randomized Controlled Trial

    Medicine (United States), Vol. 95, Núm. 6